Device Medical Device

(O49) Image Guided Therapy Und

Payments companies reported to CMS as associated with (O49) Image Guided Therapy Und. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,911associated payments (2023-2025)
23clinicians with associated payments
1company reporting

By year

2024 $1,911

Payments reported as associated with (O49) Image Guided Therapy Und, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $1,177
Cardiovascular Disease $228
Vascular & Interventional Radiology $155
Clinical Cardiac Electrophysiology $154
Pediatric Radiology $124
Hospitalist $42.91

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (O49) Image Guided Therapy Und

These are the largest totals companies reported as associated with (O49) Image Guided Therapy Und. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jasvindar Singh Saint Louis, MO Interventional Cardiology $427.85
Darshan Doshi Boston, MA Interventional Cardiology $231.89
George Chrysant Oklahoma City, OK Interventional Cardiology $159.66
Dwight Dishmon Memphis, TN Interventional Cardiology $159.21
Jayna Kelly Memphis, TN Interventional Cardiology $126.70
Seetharam Chadalavada Cincinnati, OH Vascular & Interventional Radiology $123.97
John Racadio Cincinnati, OH Pediatric Radiology $123.97
Matthew Ebinger Detroit, MI Clinical Cardiac Electrophysiology $42.92
Tiberio Frisoli Brownstown Twp, MI Cardiovascular Disease $42.92
Hussayn Alrayes Louisville, KY Interventional Cardiology $42.92

Prescribed (O49) Image Guided Therapy Und?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.